Council for Innovation Promotion

New Op-Ed from former VT Gov. Howard Dean: Supreme Court has weakened U.S. patents, cue Congress

Over the weekend, former DNC Chair and Vermont Gov. Howard Dean published an opinion piece in the Boston Herald encouraging Congress to pass the Patent Eligibility Restoration Act. The legislation, introduced by Senators Chris Coons (D-DE) and Thom Tillis (R-NC), aims to eliminate uncertainty caused by Supreme Court rulings around what types of inventions are […]

New Op-Ed from former VT Gov. Howard Dean: Supreme Court has weakened U.S. patents, cue Congress Read More »

Council for Innovation Promotion Statement on IRA Price Negotiation List

WASHINGTON (August 29, 2023) — Today, the Centers for Medicare & Medicaid Services released the initial 10 prescription drugs subject to price controls under the Inflation Reduction Act. Frank Cullen, executive director of the Council for Innovation Promotion, issued the following statement regarding the development: “Today’s announcement marks a concerning turn for America’s intellectual property

Council for Innovation Promotion Statement on IRA Price Negotiation List Read More »

New Resource: Perspectives on IP and Technology Transfer in the United States

On July 31, the National Institutes of Health (NIH) held a workshop with the intent of delving into the policies and methods that guide biomedical innovation and ensure public access to discoveries supported by the agency. The forum aimed to address the NIH’s approach to patenting and licensing biomedical inventions. Additional topics included the agency’s

New Resource: Perspectives on IP and Technology Transfer in the United States Read More »

Fact Check: The Patent Eligibility Restoration Act Does Not Allow Patenting of Naturally-Occurring Genes

Claim: The American Civil Liberties Union (ACLU) published a statement announcing that it would oppose the recently reintroduced Patent Eligibility Restoration Act (PERA) on the grounds that “If passed, the Act would allow corporations and other entities to patent laws of nature and products of nature, including naturally-occurring genes.” Correction: The Patent Eligibility Restoration Act explicitly does not allow

Fact Check: The Patent Eligibility Restoration Act Does Not Allow Patenting of Naturally-Occurring Genes Read More »

New Op-Ed from C4IP’s Board of Directors: The European Commission is set to undermine the continent’s tech industry

Last week, C4IP’s Board of Directors published an opinion piece in the Brussels Morning News on new regulations proposed by the European Commission, which would establish a “Competency Centre” at the European Union Intellectual Property Office (EUIPO) to govern the standard-essential patents (SEPs) that cover shared tech industry practices. In the piece, C4IP’s board argues

New Op-Ed from C4IP’s Board of Directors: The European Commission is set to undermine the continent’s tech industry Read More »

This Month in IP: July 2023

C4IP is recognizing patents, copyrights, and trademarks registered during the month of July for historic inventions that changed their industries and the way we live today. 1952: On July 1, the trademark for “Silly Putty” was registered. Silly Putty emerged as one of the most beloved toys of the 20th century. As its popularity soared, individuals began discovering more practical

This Month in IP: July 2023 Read More »

Scroll to Top